S 3311
American Made Pharmaceuticals Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The American Made Pharmaceuticals Act of 2023 directs the Department of Health and Human Services to establish a seven-year demonstration program designed to prioritize domestically manufactured drugs within Medicare, Medicaid, and the Children’s Health Insurance Program. This program will offer preferences like reduced cost-sharing and preferential formulary placement to drugs produced in the United States, particularly critical drugs with vulnerable supply chains. The goal is to bolster domestic pharmaceutical manufacturing and improve supply chain resilience.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.